1-35 Indication

Amoxicillin

Acute otitis media

Lower respiratory tract infection

Streptococcal pharyngitis

Ear, nose, and throat infection

Helicobacter pylori eradication, triple regimen

Amoxicillin/clavulanante

Acute otitis media

Community-acquired pneumonia

Sinusitis, infection of skin or subcutaneous tissue, infectious Disease of genitourinary system

Urinary tract infection, acute cystitis

Urinary tract infection, pyelonephritis

Azithromycin

Acute infective exacerbation of COPD, skin or tissue infection

Bacterian sinusitis

Chancroid, nongonococcal cervicitis, nongonococcal urethritis

Community-acquired pneumonia

Sexually transmitted infections

Streptococcal pharyngitis

Clarithromycin

COPD, acute exacerbation, without disk factors of pseudomonas

Community-acquired pneumonia, skin infection, sinusitis

Disseminated infection, due to M. avium-intracellulare group, prophylaxis-HIV infection, primary prevention and treatment

H. pylori GI tract infection

Streptococcal pharyngitis (group A)

Fidaxomicin

C. difficile infection

Benazepril

Hypertension

Enalapril

Heart failure

HTN

Fosinopril

Heart failure HTN

Lisinopril

ST-segment elevation MI

Heart failure with reduced ejection fraction

HTN

Benzonanate

Cough

Canagliflozin

Diabetes mellitus

Dapagliflozin

Diabetes mellitus

Heart failure with reduced ejection fraction

Chronic kidney disease

Candesarton

Heart failure

HTN

Chlorthalidone

HTN

Edema

Hydrochlorothiazide

Edema

HTN

Covid-19 mRNA Vaccines

Prevention of COVID-19 infection, unvaccinated

Prevention of COVID-19 infection, moderately or severely immunocompromised, unvaccinated

Diphtheria Toxoid

Prevention of diphtheria

Haemophilus Influenzae

Prevention of invasive H. influenzae type b (Hib) infection, children ≥6wk of age

Meningococcal Vaccine

Prevention of invasive meningococcal disease caused by serogroups ACYW-135

Prevention of invasive meningococcal disease caused by serogroup B

Pertussis Vaccine

Prevention of pertussis

Pneumococcal Vaccine

Prevention of invasive pneumococcal disease

Dulaglutide

Diabetes mellitus

Exenatide

Diabetes mellitus

Liraglutide

Diabetes mellitus

Chronic weight management

Epinephrine autoinjector

Emergency treatment of acute anaphylaxis due to allergic reactions

Ezetimibe

Familial hypercholesterolemia-homozygous, with atorvastatin or simvastatin

Mixed hyperlipidemia

Primary hypercholesterolemia

Homozygous familial sitosterolemia

Fenofibrate

Hypertrygliceridemia

Gemfibrozil

Coronary arteriosclerosis

Familial type V hyperlipoproteinemia-Fredrickson type IV hyperlipoproteinemia

Niacin

Dyslipidemia

Hydralazine

HTN

Meclizine

Motion sickness

Vertigo

Promethazine

Nausea and vomiting

Penicillin

Otitis media, mild-moderate, pneumococcal

Streptococcal pharyngitis

Erysipelas, mild infection or step-down therapy

Gingivitis

Spironolactone

Heart failure

Primary aldosteronism

HTN

Ascites, cirrhosis of liver

Triamterene/Hydrochlorothiazide

Edema

HTN